CDLX
Cardlytics, Inc.
CDLX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
CDLX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
CDLX's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
CDLX PE Valuation
CDLX has no meaningful PE right now: it lost money over the past year.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
CDLX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CDLX's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
CDLX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$6.42 | +$15.18 |
| Q2 2026 | -$18.50 | +$18.50 |
| Q1 2026 | -$17.72 | +$18.38 |
| Q4 2025 | -$19.50 | +$19.60 |
| Q3 2025 | -$21.60 | +$40.45 |
| Q2 2025 | -$37.00 | +$2.35 |
| Q1 2025 | -$36.10 | +$9.05 |
| Q4 2024 | -$39.10 | -$3.55 |
CDLX is still losing money, but far less than before: $6.42 per share over the past year, against $145.30 at its worst in early 2023.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has the edge over CDLX in the latest year-over-year earnings comparison.
CDLX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.9M | -37% |
| Q2 2026 | $36.9M | -42% |
| Q1 2026 | $34.3M | -45% |
| Q4 2025 | $56.1M | -24% |
| Q3 2025 | $52M | -22% |
| Q2 2025 | $63.2M | -9.2% |
| Q1 2025 | $61.9M | -8.4% |
| Q4 2024 | $74M | -17% |
CDLX has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -16% | +116 points |
| Q2 2026 | -15% | +5.5 points |
| Q1 2026 | -24% | -1.4 points |
| Q4 2025 | -11% | +0.4 points |
| Q3 2025 | -132% | +89 points |
| Q2 2025 | -20% | +2.5 points |
| Q1 2025 | -23% | +11 points |
| Q4 2024 | -11% | +104 points |
CDLX's operating margin was −16% last quarter, up 116 points from the same quarter a year ago.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
CDLX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.9M | -439% |
| Q2 2026 | -$8.6M | -1052% |
| Q1 2026 | -$5.7M | +$1.2M |
| Q4 2025 | $13M | +355% |
| Q3 2025 | $1.7M | +99% |
| Q2 2025 | $903K | -78% |
| Q1 2025 | -$6.8M | +$11.4M |
| Q4 2024 | $2.9M | +7.4% |
CDLX's free cash flow was −$7M over the past year, against −$1M the year before.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
CDLX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +143K shares |
| 1 year | +10% | +553K shares |
| 3 years | +55% | +2.1M shares |
| 5 years | +116% | +3.2M shares |
| Available history | +149% | +3.5M shares |
CDLX has 6M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q4 2024 | $309,000 |
| Q3 2024 | $119,000 |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over CDLX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
CDLX Net Leverage
CDLX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
CDLX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.0 | Oversold |
| Stochastic | 5.9 | Oversold |
CDLX's weekly RSI is 28 (oversold) and its Stochastic is 6 (oversold).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CDLX PE vs Communication Services Sector
CDLX has no meaningful PE right now: it lost money over the past year.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
CDLX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.11 | 32% below |
| 20 week MA | $3.25 | 56% below |
| 50 week MA | $6.64 | 78% below |
| 100 week MA | $13.8 | 90% below |
| 200 week MA | $46.7 | 97% below |
NBIS has stronger trend alignment. CDLX is above 0 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
CDLX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $649.6 | $1,430.2 | +120% |
| 2021 | $1,430.2 | $662.5 | -54% |
| 2022 | $662.5 | $48.2 | -93% |
| 2023 | $48.2 | $92.1 | +91% |
| 2024 | $92.1 | $37.3 | -60% |
| 2025 | $37.3 | $11.9 | -68% |
| 2026 YTD | $11.9 | $1.43 | -88% |
CDLX's yearly returns have swung widely, from +120% in 2020 to −93% in 2022. It's down 88% so far in 2026.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over CDLX on returns for 2026, with the stronger performance.